Adriamycin and CCNU in advanced breast cancer: A Southwest Oncology Group Study

    loading  Checking for direct PDF access through Ovid


ADRIAMYCIN AND CCNU in identical combination and drug dosages as used by Einhorn et al, was evaluated in a groupwide study of advanced breast cancer. The overall response of 16% is far less than that reported previously and suggests that this combination cannot be recommended for extensive use.

    loading  Loading Related Articles